IL10 and metabolic dysfunction-associated steatohepatitis: Overall, this study revealed the downregulation of FXR and IL-10/IL-10R-related serological, functional and pathogenic signalling mechanisms, and phenotypic abnormalities of NASH-related cardiomyopathy at systemic and cellular levels in a mouse model.